ArticleFrontiers in immunology2026

Efficacy and safety of ripertamab in immune-mediated glomerular diseases with proteinuria: an expanded real-world cohort study.

Xichao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.